vs
AXCELIS TECHNOLOGIES INC（ACLS）与GE医疗（DHC）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是AXCELIS TECHNOLOGIES INC的1.6倍（$379.6M vs $238.3M），AXCELIS TECHNOLOGIES INC净利率更高（14.4% vs -5.6%，领先20.0%），GE医疗同比增速更快（-0.0% vs -5.6%），AXCELIS TECHNOLOGIES INC自由现金流更多（$-8.9M vs $-166.4M），过去两年GE医疗的营收复合增速更高（1.2% vs -2.8%）
Axcelis Technologies是一家美国半导体设备供应商，1995年成立，总部位于美国马萨诸塞州贝弗利。公司面向全球半导体制造行业，从事半导体生产核心设备的设计、制造及服务，主营产品包括高中电流、高能离子注入系统以及半导体芯片制造用固化系统。
GE医疗是一家总部位于美国伊利诺伊州芝加哥市的医疗科技企业，业务涵盖四大板块：医疗影像设备，包括分子成像、CT、核磁共振、妇科健康筛查及X光系统；超声设备；患者护理解决方案，聚焦远程患者监测、麻醉呼吸护理、心脏诊断及婴幼儿护理；此外还涉及医药相关领域，是全球医疗行业的知名企业。
ACLS vs DHC — 直观对比
营收规模更大
DHC
是对方的1.6倍
$238.3M
营收增速更快
DHC
高出5.6%
-5.6%
净利率更高
ACLS
高出20.0%
-5.6%
自由现金流更多
ACLS
多$157.5M
$-166.4M
两年增速更快
DHC
近两年复合增速
-2.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $238.3M | $379.6M |
| 净利润 | $34.3M | $-21.2M |
| 毛利率 | 47.0% | — |
| 营业利润率 | 15.2% | -12.6% |
| 净利率 | 14.4% | -5.6% |
| 营收同比 | -5.6% | -0.0% |
| 净利润同比 | -31.3% | 75.7% |
| 每股收益（稀释后） | $1.11 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACLSDHC
| Q4 25 | $238.3M | $379.6M | ||
| Q3 25 | $213.6M | $388.7M | ||
| Q2 25 | $194.5M | $382.7M | ||
| Q1 25 | $192.6M | $386.9M | ||
| Q4 24 | $252.4M | $379.6M | ||
| Q3 24 | $256.6M | $373.6M | ||
| Q2 24 | $256.5M | $371.4M | ||
| Q1 24 | $252.4M | $370.8M |
净利润ACLSDHC
| Q4 25 | $34.3M | $-21.2M | ||
| Q3 25 | $26.0M | $-164.0M | ||
| Q2 25 | $31.4M | $-91.6M | ||
| Q1 25 | $28.6M | $-9.0M | ||
| Q4 24 | $50.0M | $-87.4M | ||
| Q3 24 | $48.6M | $-98.7M | ||
| Q2 24 | $50.9M | $-97.9M | ||
| Q1 24 | $51.6M | $-86.3M |
毛利率ACLSDHC
| Q4 25 | 47.0% | — | ||
| Q3 25 | 41.6% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 46.1% | — | ||
| Q4 24 | 46.0% | — | ||
| Q3 24 | 42.9% | — | ||
| Q2 24 | 43.8% | — | ||
| Q1 24 | 46.0% | — |
营业利润率ACLSDHC
| Q4 25 | 15.2% | -12.6% | ||
| Q3 25 | 11.7% | -43.4% | ||
| Q2 25 | 14.9% | -24.5% | ||
| Q1 25 | 15.1% | -2.7% | ||
| Q4 24 | 21.6% | -26.1% | ||
| Q3 24 | 18.3% | -26.5% | ||
| Q2 24 | 20.6% | -23.0% | ||
| Q1 24 | 22.4% | -23.7% |
净利率ACLSDHC
| Q4 25 | 14.4% | -5.6% | ||
| Q3 25 | 12.2% | -42.2% | ||
| Q2 25 | 16.1% | -23.9% | ||
| Q1 25 | 14.8% | -2.3% | ||
| Q4 24 | 19.8% | -23.0% | ||
| Q3 24 | 18.9% | -26.4% | ||
| Q2 24 | 19.8% | -26.3% | ||
| Q1 24 | 20.4% | -23.3% |
每股收益（稀释后）ACLSDHC
| Q4 25 | $1.11 | $-0.09 | ||
| Q3 25 | $0.83 | $-0.68 | ||
| Q2 25 | $0.98 | $-0.38 | ||
| Q1 25 | $0.88 | $-0.04 | ||
| Q4 24 | $1.54 | $-0.37 | ||
| Q3 24 | $1.49 | $-0.41 | ||
| Q2 24 | $1.55 | $-0.41 | ||
| Q1 24 | $1.57 | $-0.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $374.3M | $105.4M |
| 总债务越低越好 | — | $2.4B |
| 股东权益账面价值 | $1.0B | $1.7B |
| 总资产 | $1.4B | $4.4B |
| 负债/权益比越低杠杆越低 | — | 1.47× |
8季度趋势，按日历期对齐
现金及短期投资ACLSDHC
| Q4 25 | $374.3M | $105.4M | ||
| Q3 25 | $449.6M | $201.4M | ||
| Q2 25 | $549.8M | $141.8M | ||
| Q1 25 | $587.1M | $302.6M | ||
| Q4 24 | $571.3M | $144.6M | ||
| Q3 24 | $579.4M | $256.5M | ||
| Q2 24 | $548.3M | $265.6M | ||
| Q1 24 | $530.2M | $207.1M |
总债务ACLSDHC
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $3.1B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ACLSDHC
| Q4 25 | $1.0B | $1.7B | ||
| Q3 25 | $1.0B | $1.7B | ||
| Q2 25 | $1.0B | $1.9B | ||
| Q1 25 | $1.0B | $1.9B | ||
| Q4 24 | $1.0B | $2.0B | ||
| Q3 24 | $975.6M | $2.0B | ||
| Q2 24 | $934.9M | $2.1B | ||
| Q1 24 | $901.7M | $2.2B |
总资产ACLSDHC
| Q4 25 | $1.4B | $4.4B | ||
| Q3 25 | $1.4B | $4.7B | ||
| Q2 25 | $1.3B | $4.8B | ||
| Q1 25 | $1.3B | $5.0B | ||
| Q4 24 | $1.3B | $5.1B | ||
| Q3 24 | $1.3B | $5.3B | ||
| Q2 24 | $1.3B | $5.3B | ||
| Q1 24 | $1.3B | $5.3B |
负债/权益比ACLSDHC
| Q4 25 | — | 1.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $-19.6M |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | $-166.4M |
| 自由现金流率自由现金流/营收 | -3.7% | -43.8% |
| 资本支出强度资本支出/营收 | 1.0% | 38.7% |
| 现金转化率经营现金流/净利润 | -0.19× | — |
| 过去12个月自由现金流最近4个季度 | $107.0M | $-280.3M |
8季度趋势，按日历期对齐
经营现金流ACLSDHC
| Q4 25 | $-6.6M | $-19.6M | ||
| Q3 25 | $45.4M | $-49.3M | ||
| Q2 25 | $39.7M | $53.0M | ||
| Q1 25 | $39.8M | $-3.2M | ||
| Q4 24 | $12.8M | $112.2M | ||
| Q3 24 | $45.7M | $21.1M | ||
| Q2 24 | $40.1M | $44.3M | ||
| Q1 24 | $42.2M | $28.6M |
自由现金流ACLSDHC
| Q4 25 | $-8.9M | $-166.4M | ||
| Q3 25 | $43.3M | $-89.8M | ||
| Q2 25 | $37.7M | $18.8M | ||
| Q1 25 | $34.8M | $-42.9M | ||
| Q4 24 | $8.1M | $-89.5M | ||
| Q3 24 | $41.8M | $-26.1M | ||
| Q2 24 | $38.1M | $3.3M | ||
| Q1 24 | $40.6M | $-18.1M |
自由现金流率ACLSDHC
| Q4 25 | -3.7% | -43.8% | ||
| Q3 25 | 20.3% | -23.1% | ||
| Q2 25 | 19.4% | 4.9% | ||
| Q1 25 | 18.1% | -11.1% | ||
| Q4 24 | 3.2% | -23.6% | ||
| Q3 24 | 16.3% | -7.0% | ||
| Q2 24 | 14.8% | 0.9% | ||
| Q1 24 | 16.1% | -4.9% |
资本支出强度ACLSDHC
| Q4 25 | 1.0% | 38.7% | ||
| Q3 25 | 0.9% | 10.4% | ||
| Q2 25 | 1.0% | 8.9% | ||
| Q1 25 | 2.6% | 10.2% | ||
| Q4 24 | 1.8% | 53.1% | ||
| Q3 24 | 1.5% | 12.6% | ||
| Q2 24 | 0.8% | 11.0% | ||
| Q1 24 | 0.6% | 12.6% |
现金转化率ACLSDHC
| Q4 25 | -0.19× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.27× | — | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.26× | — | ||
| Q3 24 | 0.94× | — | ||
| Q2 24 | 0.79× | — | ||
| Q1 24 | 0.82× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACLS
| Products | $224.6M | 94% |
| Services | $13.7M | 6% |
DHC
| Senior Housing Operating Portfolio Segment | $323.4M | 85% |
| Rental Income | $56.2M | 15% |
